Insider Transactions in Q2 2021 at Amicus Therapeutics, Inc. (FOLD)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
22,000
-2.45%
|
$220,000
$10.26 P/Share
|
|
Jun 15
2021
|
John F Crowley Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
22,000
+2.39%
|
$88,000
$4.38 P/Share
|
|
Jun 10
2021
|
Eiry Roberts |
BUY
Grant, award, or other acquisition
|
Direct |
22,759
+50.0%
|
-
|
|
Jun 10
2021
|
Craig A Wheeler |
BUY
Grant, award, or other acquisition
|
Direct |
10,115
+24.53%
|
-
|
|
Jun 10
2021
|
Burke W Whitman |
BUY
Grant, award, or other acquisition
|
Direct |
10,115
+14.94%
|
-
|
|
Jun 10
2021
|
Michael Raab |
BUY
Grant, award, or other acquisition
|
Direct |
10,115
+21.58%
|
-
|
|
Jun 10
2021
|
Michael Aaron Kelly |
BUY
Grant, award, or other acquisition
|
Direct |
10,115
+34.8%
|
-
|
|
Jun 10
2021
|
Lynn Dorsey Bleil |
BUY
Grant, award, or other acquisition
|
Direct |
10,115
+14.34%
|
-
|
|
Jun 10
2021
|
Margaret G Mcglynn |
BUY
Grant, award, or other acquisition
|
Direct |
10,115
+21.01%
|
-
|
|
Jun 10
2021
|
Glenn Sblendorio |
BUY
Grant, award, or other acquisition
|
Direct |
10,115
+18.68%
|
-
|
|
Jun 10
2021
|
Robert Essner Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,115
+24.53%
|
-
|
|
Jun 07
2021
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
10,514
-2.25%
|
$105,140
$10.01 P/Share
|
|
Jun 07
2021
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
73,110
+2.6%
|
$219,330
$3.71 P/Share
|
|
Jun 07
2021
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
17,350
-3.66%
|
$173,500
$10.08 P/Share
|
|
Jun 07
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
29,500
-3.25%
|
$295,000
$10.01 P/Share
|
|
Jun 07
2021
|
John F Crowley Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
22,000
+1.19%
|
$110,000
$5.42 P/Share
|
|
Jun 01
2021
|
Burke W Whitman |
BUY
Open market or private purchase
|
Direct |
1,500
+3.06%
|
$13,500
$9.24 P/Share
|
|
May 25
2021
|
Lynn Dorsey Bleil |
BUY
Open market or private purchase
|
Direct |
28,605
+36.25%
|
$228,840
$8.74 P/Share
|
|
May 18
2021
|
Michael Raab |
BUY
Exercise of conversion of derivative security
|
Direct |
5,634
+17.46%
|
$39,438
$7.56 P/Share
|
|
May 03
2021
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
10,514
-2.49%
|
$105,140
$10.27 P/Share
|
|
May 03
2021
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,514
+2.43%
|
$63,084
$6.45 P/Share
|
|
May 03
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
7,500
-0.84%
|
$75,000
$10.28 P/Share
|
|
May 03
2021
|
Burke W Whitman |
BUY
Open market or private purchase
|
Direct |
1,500
+3.16%
|
$15,000
$10.21 P/Share
|
|
May 03
2021
|
Margaret G Mcglynn |
SELL
Open market or private sale
|
Direct |
10,000
-26.37%
|
$100,000
$10.27 P/Share
|
|
May 03
2021
|
Margaret G Mcglynn |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+20.87%
|
$70,000
$7.51 P/Share
|
|
Apr 22
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
7,683
-0.85%
|
$76,830
$10.01 P/Share
|
|
Apr 15
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
22,000
-2.39%
|
$220,000
$10.09 P/Share
|
|
Apr 15
2021
|
John F Crowley Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
22,000
+2.33%
|
$132,000
$6.45 P/Share
|
|
Apr 15
2021
|
Samantha Prout Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
660
-0.74%
|
$6,600
$10.33 P/Share
|
|
Apr 15
2021
|
Samantha Prout Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,201
+21.4%
|
-
|
|
Apr 06
2021
|
Ellen Rosenberg Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,501
+7.83%
|
-
|
|
Apr 06
2021
|
Daphne Quimi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,295
+6.23%
|
-
|
|
Apr 06
2021
|
Bradley L Campbell President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
33,165
+7.45%
|
-
|
|
Apr 06
2021
|
John F Crowley Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
78,389
+8.01%
|
-
|
|
Apr 06
2021
|
Hung Do Chief Science Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,501
+4.37%
|
-
|
|
Apr 06
2021
|
David Michael Clark Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,883
+8.83%
|
-
|
|
Apr 01
2021
|
Burke W Whitman |
BUY
Open market or private purchase
|
Direct |
1,500
+3.26%
|
$15,000
$10.0 P/Share
|
|
Apr 01
2021
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
7,500
-0.9%
|
$75,000
$10.0 P/Share
|
|
Apr 01
2021
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
10,514
-2.7%
|
$105,140
$10.03 P/Share
|
|
Apr 01
2021
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,514
+2.63%
|
$63,084
$6.45 P/Share
|